Screener
Phibro Animal Health PAHC Animal Health — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Phibro Animal Health’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:25 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056280
| For the Periods Ended March 31 | Three Months / 2026 | Three Months / 2025 | Nine Months / 2026 | Nine Months / 2025 |
|---|---|---|---|---|
| Net sales | $291,225 | $258,377 | $864,658 | $670,318 |
| Cost of sales | 176,315 | 166,221 | 517,218 | 412,547 |
| Selling, general and administrative expenses(1) | 54,935 | 46,133 | 154,385 | 131,513 |
| Add: Depreciation and amortization | 11,128 | 11,369 | 34,310 | 29,318 |
| Add: Acquisition-related cost of goods sold(2) | — | 1,708 | 1,956 | 3,342 |
| Add: Phibro Forward income growth initiatives implementation costs - cost of goods sold (3) | — | 3,798 | — | 3,798 |
| Add: Phibro Forward income growth initiatives implementation costs - SG&A (3) | — | 1,771 | — | 1,771 |
| Subtract: Insurance proceeds(4) | — | (1,546) | (1,177) | (2,803) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phibro Animal Health's animal health — D&A?
- Phibro Animal Health (PAHC) reported animal health — D&A of $11.13M in Q1 2026.
- How has Phibro Animal Health's animal health — D&A changed year-over-year?
- Phibro Animal Health's animal health — D&A decreased by 2.1% year-over-year, from $11.37M to $11.13M.
- What is the long-term trend for Phibro Animal Health's animal health — D&A?
- Over 3 years (2022 to 2025), Phibro Animal Health's animal health — D&A has grown at a 14.8% compound annual growth rate (CAGR), from $26.76M to $40.48M.
- What does animal health — D&A mean?
- This represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the animal health segment. It reflects the wear and tear of manufacturing equipment and the consumption of acquired intellectual property or patents. Analyzing this metric provides insight into the capital intensity and the ongoing reinvestment needs of the segment.
Ask your AI about Phibro Animal Health's animal health — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude